GlassScriptPhysician profile
Philip Gilbo
NPI 1932528601
$1,657.65
in general payments reported to CMS, 2019-2025
31 companies · $771 in 2025
The $771 reported for 2025 was more than what 80% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.49 · 2020: $61.45 · 2021: $13.74 · 2022: $12.49 · 2023: $53.43 · 2024: $708 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $171.55 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm |
| Genentech USA, INC. | $143.93 | 2024-2025 | Tecentriq, Venclexta, Alecensa |
| E.R. Squibb & Sons, L.L.C. | $115.19 | 2020-2025 | Opdualag |
| Abbvie INC. | $107.07 | 2024-2025 | |
| Eisai INC. | $103.54 | 2022-2025 | |
| Incyte Corporation | $101.40 | 2024-2025 | Monjuvi, Pemazyre, Zynyz |
| Astrazeneca Pharmaceuticals LP | $81.34 | 2020-2025 | Tagrisso, Enhertu |
| Rigel Pharmaceuticals, INC. | $77.39 | 2024-2025 | Rezlidhia, Tavalisse, Gavreto |
| Merck Sharp & Dohme LLC | $67.59 | 2019-2025 | Keytruda |
| Celgene Corporation | $57.40 | 2024-2025 | Reblozyl |
| Emd Serono, INC. | $46.69 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $44.12 | 2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $43.58 | 2024 | Darzalex, Erleada |
| Takeda Pharmaceuticals U.S.A., INC. | $42.36 | 2024-2025 | Ninlaro, Alunbrig |
| Regeneron Healthcare Solutions, INC. | $38.94 | 2024 | Libtayo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $38.56 | 2024-2025 | Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $36.82 | 2024-2025 | |
| Mirati Therapeutics, INC. | $34.52 | 2024 | Krazati |
| Jazz Pharmaceuticals INC. | $34.17 | 2024-2025 | |
| Pfizer INC. | $33.74 | 2024 | |
| Novartis Pharmaceuticals Corporation | $32.97 | 2023 | |
| Teleflex LLC | $23.49 | 2025 | Barrigel |
| Array Biopharma INC | $21.16 | 2024 | Mektovi, Lorbrena, Braftovi |
| Azurity Pharmaceuticals, INC. | $20.48 | 2025 | Vivimusta |
| Progenics Pharmaceuticals, INC. | $20.46 | 2023 | Pylarify |
| Exelixis INC. | $20.20 | 2025 | Cabometyx |
| Stemline Therapeutics INC. | $20.06 | 2024 | Orserdu |
| Biocon Biologics INC | $19.98 | 2024 | Fulphila |
| Servier Pharmaceuticals LLC | $19.86 | 2024 | |
| Coherus Oncology, INC. | $19.77 | 2024 | |
| Adaptive Biotechnologies Corporation | $19.32 | 2025 | Clonoseq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Gilbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.